Losartan Pot/HCTZ 50/12 recalled over manufacturing violations
- Recall date
- March 12, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Direct Rx recalls Losartan Pot/HCTZ 50/12.5 mg 90 Tabs Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Torrent Phar…
- Recall number
- D-0032-2021
- FDA classification
- Class II
- Brand / firm
- Direct Rx
- Sold / distributed
- FL
Why it was recalled
CGMP deviation: Trace amounts of impurity detected to be N-Methylnitrosobutyric acid (NMBA) in the API.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Losartan Pot/HCTZ 50/12.5 mg 90 Tabs Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Torrent Pharma, Inc. Basking Ridge, NJ 07920 NDC 61919-040-90
Get recall alerts
Free email alert whenever Direct Rx has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Direct Rx